Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting ...

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track program after agency scientists flagged safety and efficacy concerns, ...